1-1 of 1
Sho Yamazaki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CAMK2G is identified as a novel therapeutic target for myelofibrosis

Masashi Miyauchi, Ken Sasaki, Yuki Kagoya, Kazuki Taoka, Yosuke Masamoto, Sho Yamazaki, Shunya Arai, Hideaki Mizuno, Mineo Kurokawa
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1585–1597.
https://doi.org/10.1182/bloodadvances.2020003303
Published: 2022
Includes: Supplemental data